Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

SoftBank bid for ARM catches some hedge funds off guard

Published 19/07/2016, 16:51
© Reuters. An ARM and SoftBank Group branded board is displayed at a news conference in London

By Maiya Keidan

LONDON (Reuters) - A Dallas hedge fund was among investors betting on a fall in the price of ARM Holdings (LON:ARM) when SoftBank Group's surprise $32 billion (£24.3 billion) bid sent shares in the British chip designer surging nearly 50 percent.

The set-back for such hedge funds, who position themselves to profit from swings in stock prices, comes at a difficult time for the industry as many peers have seen their performance slide and some investors have even demanded their money back.

Data from Britain's regulator, the Financial Conduct Authority, shows that Maverick Capital had a substantial outstanding short position in ARM of roughly 1.2 percent of its shares when the SoftBank bid was announced on Monday.

The data shows that Maverick had a short position of 0.67 percent as of Jan. 6 and increased that to 1.2 percent on May 3.

Maverick declined to comment.

Investors use short selling strategies to bet that a stock price will fall. They borrow shares and sell them in the hope the price will fall and they can buy them back later for less, and return them to the original owner for a profit.

But if the price rises, the bet backfires as the short-seller still has to buy the shares to return them at some point.

SoftBank swooped on Britain's most valuable technology company in a bid to lead the next wave of digital innovation with a chip designer that powers the mobile phone industry.

Maverick was not alone in betting on gloomier prospects for ARM. The amount of ARM stock out on loan to short-sellers stood at 5.6 percent on Friday ahead of the takeover bid, up from 2 percent in January.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Earlier this year, Maverick also nearly doubled its stake in drugmaker Allergan before a planned $150 billion deal with Pfizer (NYSE:PFE) unravelled and Allergan's stock dropped.

Hedge funds who buy and borrow stock have had a particularly tough time in volatile markets this year.

Their returns fell 0.96 percent in the first six months of 2016 while investors demanded the return of $2 billion, according to industry data from Eurekahedge.

Greenlight Capital and QVT Financial both held short positions of greater than 0.5 percent of ARM during 2013 and 2014 but they fell below the disclosure threshold in 2015.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.